Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinica…
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Iovance Biotherapeutics, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. | FMP | High | United States | San Diego | |
| Krystal Biotech, Inc. | FMP | High | United States | Pittsburgh | |
| Ocean Biomedical, Inc. | FMP | High | United States | Providence | |
| CureVac N.V. | FMP | High | Germany | Tübingen | |
| Sarepta Therapeutics, Inc. | FMP | High | United States | Cambridge | |
| Madrigal Pharmaceuticals, Inc. | FMP | High | United States | West Conshohocken | |
| Apellis Pharmaceuticals, Inc. | FMP | High | United States | Waltham | |
| CohBar, Inc. | FMP | High | United States | Menlo Park | |
| PTC Therapeutics, Inc. | FMP | High | United States | South Plainfield | |
| Hepion Pharmaceuticals, Inc. | FMP | High | United States | Edison | |
| Rain Therapeutics Inc. | FMP | High | United States | Newark |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |